Head & Neck/Thyroid Cancer Tislelizumab Plus Chemotherapy for Recurrent/Metastatic Nasopharyngeal Cancer: RATIONALE-309
Head & Neck/Thyroid Cancer Strategy for De-Escalating Radiation Therapy for Patients With Oropharyngeal Cancer
Head & Neck/Thyroid Cancer Apatinib vs Placebo in Patients With Locally Advanced or Metastatic, Radioactive Iodine–Refractory Differentiated Thyroid Cancer
